YC W20
Ansa Biotechnologies
Next-generation DNA synthesis using enzymes
About
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Founders
- Dan Lin-Arlow
- Sebastian Palluk
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Ansa Biotechnologies.
See family office activityIndustry & Focus
HealthcareIndustrial BioSynthetic BiologyBiotech